Reduction of Methylglyoxal-Induced Glycation by Pyridoxamine Improves Adipose Tissue Microvascular Lesions

Background and Aims. Adipose tissue dysfunction results from many factors, including glycation-induced microvascular damages. We tested the usefulness of inhibiting methylglyoxal-induced glycation to adipose tissue microvasculature in this work, using the antioxidant and dicarbonyl scavenger drug py...

Full description

Saved in:
Bibliographic Details
Main Authors: Tiago Rodrigues, Paulo Matafome, Daniela Santos-Silva, Cristina Sena, Raquel Seiça
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2013/690650
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559083451842560
author Tiago Rodrigues
Paulo Matafome
Daniela Santos-Silva
Cristina Sena
Raquel Seiça
author_facet Tiago Rodrigues
Paulo Matafome
Daniela Santos-Silva
Cristina Sena
Raquel Seiça
author_sort Tiago Rodrigues
collection DOAJ
description Background and Aims. Adipose tissue dysfunction results from many factors, including glycation-induced microvascular damages. We tested the usefulness of inhibiting methylglyoxal-induced glycation to adipose tissue microvasculature in this work, using the antioxidant and dicarbonyl scavenger drug pyridoxamine. Methods. A group of Wistar rats was treated daily with methylglyoxal (MG, 75 mg/Kg/day, 8 weeks). Half of this group was treated with pyridoxamine in the following 4 weeks (Pyr) (100 mg/Kg/day) and the other half did not have any further treatment (MG). A group of Wistar rats without MG treatment was used as control (C). Results. MG group showed decreased HDL cholesterol and increased plasma free fatty acids levels, what was reverted by pyridoxamine. MG also caused an increase of tissue CEL levels (glycation marker), as well as increased staining of PAS and Masson Trichrome-positive components. Pyridoxamine led to CEL and TGF-β levels similar to those observed in control rats and inhibited the accumulation of PAS and Masson Trichrome-positive components. MG caused a decrease of Bcl-2/Bax ratio (marker of apoptosis) and vWF staining (microvascular marker), what was partially reverted by the treatment with pyridoxamine. Conclusions. Preventing methylglyoxal-induced accumulation of glycated and fibrotic materials using pyridoxamine improves the microvascular lesions of the adipose tissue.
format Article
id doaj-art-81e29a46281b4a72859586f1804cc943
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-81e29a46281b4a72859586f1804cc9432025-02-03T01:30:58ZengWileyJournal of Diabetes Research2314-67452314-67532013-01-01201310.1155/2013/690650690650Reduction of Methylglyoxal-Induced Glycation by Pyridoxamine Improves Adipose Tissue Microvascular LesionsTiago Rodrigues0Paulo Matafome1Daniela Santos-Silva2Cristina Sena3Raquel Seiça4Laboratory of Physiology, Institute of Biomedical Research on Light and Image (IBILI), Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, PortugalLaboratory of Physiology, Institute of Biomedical Research on Light and Image (IBILI), Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, PortugalLaboratory of Physiology, Institute of Biomedical Research on Light and Image (IBILI), Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, PortugalLaboratory of Physiology, Institute of Biomedical Research on Light and Image (IBILI), Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, PortugalLaboratory of Physiology, Institute of Biomedical Research on Light and Image (IBILI), Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, PortugalBackground and Aims. Adipose tissue dysfunction results from many factors, including glycation-induced microvascular damages. We tested the usefulness of inhibiting methylglyoxal-induced glycation to adipose tissue microvasculature in this work, using the antioxidant and dicarbonyl scavenger drug pyridoxamine. Methods. A group of Wistar rats was treated daily with methylglyoxal (MG, 75 mg/Kg/day, 8 weeks). Half of this group was treated with pyridoxamine in the following 4 weeks (Pyr) (100 mg/Kg/day) and the other half did not have any further treatment (MG). A group of Wistar rats without MG treatment was used as control (C). Results. MG group showed decreased HDL cholesterol and increased plasma free fatty acids levels, what was reverted by pyridoxamine. MG also caused an increase of tissue CEL levels (glycation marker), as well as increased staining of PAS and Masson Trichrome-positive components. Pyridoxamine led to CEL and TGF-β levels similar to those observed in control rats and inhibited the accumulation of PAS and Masson Trichrome-positive components. MG caused a decrease of Bcl-2/Bax ratio (marker of apoptosis) and vWF staining (microvascular marker), what was partially reverted by the treatment with pyridoxamine. Conclusions. Preventing methylglyoxal-induced accumulation of glycated and fibrotic materials using pyridoxamine improves the microvascular lesions of the adipose tissue.http://dx.doi.org/10.1155/2013/690650
spellingShingle Tiago Rodrigues
Paulo Matafome
Daniela Santos-Silva
Cristina Sena
Raquel Seiça
Reduction of Methylglyoxal-Induced Glycation by Pyridoxamine Improves Adipose Tissue Microvascular Lesions
Journal of Diabetes Research
title Reduction of Methylglyoxal-Induced Glycation by Pyridoxamine Improves Adipose Tissue Microvascular Lesions
title_full Reduction of Methylglyoxal-Induced Glycation by Pyridoxamine Improves Adipose Tissue Microvascular Lesions
title_fullStr Reduction of Methylglyoxal-Induced Glycation by Pyridoxamine Improves Adipose Tissue Microvascular Lesions
title_full_unstemmed Reduction of Methylglyoxal-Induced Glycation by Pyridoxamine Improves Adipose Tissue Microvascular Lesions
title_short Reduction of Methylglyoxal-Induced Glycation by Pyridoxamine Improves Adipose Tissue Microvascular Lesions
title_sort reduction of methylglyoxal induced glycation by pyridoxamine improves adipose tissue microvascular lesions
url http://dx.doi.org/10.1155/2013/690650
work_keys_str_mv AT tiagorodrigues reductionofmethylglyoxalinducedglycationbypyridoxamineimprovesadiposetissuemicrovascularlesions
AT paulomatafome reductionofmethylglyoxalinducedglycationbypyridoxamineimprovesadiposetissuemicrovascularlesions
AT danielasantossilva reductionofmethylglyoxalinducedglycationbypyridoxamineimprovesadiposetissuemicrovascularlesions
AT cristinasena reductionofmethylglyoxalinducedglycationbypyridoxamineimprovesadiposetissuemicrovascularlesions
AT raquelseica reductionofmethylglyoxalinducedglycationbypyridoxamineimprovesadiposetissuemicrovascularlesions